Forward P/S Multiple: Alphatec (ATEC)

Alphatec Holdings, Inc. - graphic logo of issuer ATEC

Neurosurgeons' demand for titanium implants continues to drive growth, which is why this forward price-to-sales ratio on the GURU.Markets platform demonstrates an upward trend for Alphatec Holdings, Inc. (ATEC). Growth is fueled by expansion within the spinal systems niche and the acquisition of distributors. A steady stream of revenue from equipment implementation is turning the business into a cash cow, while the 1.30 metric indicates the status of the current valuation relative to future sales.

atecspine.com - ATEC Market Cap to Projected Revenue (period 07/04/2022 - 11/15/2026)

Summary analytical data breakdowns for Alphatec Holdings, Inc. (ATEC)

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company analysis:ATEC (ATEC Spine)
Product sample of Alphatec Corp

Conservative capital requires confirmation of business resilience through the price-to-sales ratio to avoid value traps. The projected P/S dynamics measure the ability of Alphatec Holdings, Inc. (ATEC) to pass costs onto the market, which, for a high-tech neurosurgery brand, is validated by premium demand for precision software and innovative spinal fixation systems.

Who Alphatec Holdings, Inc. competes with

Forward P/S Multiple BSX (bostonscientific.com)|EW: Market Cap to Projected Revenue|ResMed - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Corporation|ZBH: Forward P/S Multiple|COO - Market Cap to Expected Sales Ratio|ALGN (Align Corp) - Forward P/S Multiple|Globus Medical Corp (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Artivion, Inc. AORT|Forward P/S Multiple ENOV (enovis.com)|Forward P/S Multiple Integra LifeSciences Corp IART|ESTA - Price-to-Projected Revenue Ratio|BBNX: Price-to-Projected Revenue Ratio|IRMD (IRADIMED CORPORATION) - Forward Price-to-Revenue Multiple|Embecta Corp. - Forward Price to Sales|TNDM (Tandem Corp) - Forward P/S Multiple|Market Cap to Future Revenue Ratio AxoGen Inc AXGN|Price-to-Projected Revenue Ratio SI-BONE Inc (SIBN)|Orthofix Medical Inc. (OFIX) - Projected Price to Revenue|Forward P/S Multiple BVS (bioventus.com)|Forward P/S Multiple OrthoPediatrics Inc. KIDS|Treace Medical Concepts Inc - Forward P/S Multiple|Market Cap to Expected Sales Ratio Blade Air Mobility SRTA|Carlsmed (CARL) - Price-to-Projected Revenue Ratio|Future Price to Revenue RXST (RxSight Ophthalmic)|Price-to-Projected Revenue Ratio clearpointneuro.com|Forward Price-to-Revenue Multiple Stereotaxis, Inc. (STXS)|Forward P/S Multiple STIM|SGHT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Projected Revenue|NSPR: Forward Price-to-Revenue Multiple|Jin Medical - Price to Expected Revenue Ratio|VANI (Vivani Medical Inc) - Forward Price-to-Revenue Multiple|Market Cap to Projected Revenue XTNT|NMTC (n1mtc.com) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Modular Medical MODD|Price-to-Projected Revenue Ratio myomo.com (MYO)|Price-to-Projected Revenue Ratio COCH (envoymedical.com)|Price-to-Projected Revenue Ratio Vivos Therapeutics Inc VVOS|enVVeno Medical Corp. - Price-to-Projected Revenue Ratio|SINT: Forward Price-to-Revenue Multiple|TNON (Tenon Medical, Inc.) - Market Cap to Projected Revenue|Lifeward Ltd. (LFWD) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Autonomix (AMIX)|Price-to-Projected Revenue Ratio INVO Fertility|Bone Biologics Corp. (BBLG) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple AXNX (Axonics Modulation Technologies)|BIOL (Biolase, Inc.) - Forward Price to Sales|Forward P/S Multiple DYNT (dynatronics.com)|Forward Price to Sales FNA|INVO Bioscience - Forward P/S Multiple